Bisoprolol* or metoprolol succinate are first-choice beta-blockers for patients with atrial fibrillation as they are prescribed once-daily and do not require dose adjustment in patients with renal impairment. Bisoprolol is preferred as it is more cardioselective than metoprolol and may cause more bradycardia.
Read moreWhat is P AFib?
Paroxysmal AFib are episodes of AFib that occur occasionally and usually stop spontaneously . Episodes can last a few seconds, hours or a few days before stopping and returning to normal sinus rhythm, which is the heart’s normal rhythm. Some people may have single episodes of AFib.
Read moreWhat are the two types of AFib?
Types. Atrial fibrillation is a type of arrhythmia. There are four main types of atrial fibrillation—paroxysmal, persistent, long-term persistent, and permanent atrial fibrillation . The type of atrial fibrillation that you have depends on how often atrial fibrillation occurs and how it responds to treatment.
Read moreWhich drug is contraindicated in atrial fibrillation?
Beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and intravenous amiodarone are contraindicated in these patients; flecainide or amiodarone can be used instead.
Read moreWho are beta-blockers contraindicated?
Traditional contraindications to beta-blockers are peripheral vascular diseases, diabetes mellitus, chronic obstructive pulmonary disease (COPD) and asthma .
Read moreWhy are beta-blockers contraindicated in arrhythmia?
Use of Beta-blockers in Supraventricular Arrhythmias Atrial Flutter Beta-blockers have not been very effective for conversion of atrial flutter to sinus rhythm However, they are effective, to a certain degree, for ventricular rate control and are, therefore, indicated in stable patients.
Read moreShould β blockers be used in patients with heart failure and atrial fibrillation?
In AF, beta-blockers are preferred as a rate-control agent in patients after myocardial infarction and in patients with congestive heart failure. They may be avoided in patients with chronic pulmonary disease and at risk of bronchoconstriction.5 Ara 2015
Read more